MRVI Stock Analysis: Buy, Sell, or Hold?

MRVI - Maravai LifeSciences Holdings, Inc. Class A Common Stock

PHARMACEUTICAL PREPARATIONS
$4.97
-0.02 (-0.30%) ▼
5d: -1.49%
30d: +15.73%
90d: +57.62%
BUY
HIGH Confidence
Analysis Updated: Jun 12, 2026 12:00 AM ET
Earnings: Aug 10, 2026

Get Alerted When MRVI Hits Your Target Price

Join 10,000+ traders who never miss a move

You're in! Check your email to confirm and set your target price.
100% Free No spam, ever Unsubscribe anytime

Interactive Price Chart (1 Month)

Loading chart...

Loading historical data...

💡
Bottom Line:
✅ BUY SIGNAL: MRVI shows strong fundamentals and good volume confirmation. Solid entry point despite slightly high pricing.
See Forward Earnings Fair Value & Price Prediction →

In-depth Analysis How we analyze

Valuation Analysis: MRVI is currently trading at $4.96, which is considered slightly high relative to its 30-day fair value range of $4.31 to $5.00.

Technical Outlook: Technically, MRVI is in a strong uptrend. Immediate support is located at $4.34, while resistance sits at $5.21.

Market Sentiment: MRVI has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $5.70 (+14.5%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.

Quick Decision Summary

Current Position SLIGHTLY HIGH
Historical Trading Range $4.31 - $5.00
Company Quality Score 62/100 (BUY)
Volume Confirmation HIGH
Confidence Score 76.3%

All Signals

  • BULLISH: Strong technical setup (75/100)
  • BULLISH: High volume confirmation
  • BULLISH: Trading below Wall St target ($5.70)

Trading Range Analysis

30-Day Trading Range $4.31 - $5.00
Current vs Trading Range SLIGHTLY HIGH

Support & Resistance Levels

Support Level $4.34
Resistance Level $5.21
Current Trend Strong Uptrend
Technical data as of Jun 9, 2026

Fundamental Context

Forward P/E (Next Year Est.) -53.55
Wall Street Target $5.70 (+14.5%)
Revenue Growth (YoY) 40.5%
Earnings Growth (YoY) -32.7%
Profit Margin -51.1%
Share & Embed Analysis

Found this analysis useful? Share it with your community or embed the live chart on your blog.

Tweet Reddit
bloggers & journalists: you are free to use our charts with attribution.
Last updated: June 15, 2026 12:38 PM ET
Data refreshes hourly during market hours. Next update: 1:38 PM
🔥 Top Stocks Breaking Out Now
Ticker Score Recommendation Change %
Technical Signals Check
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL

Unlock Insider Activity

See real-time buying/selling by company executives for MRVI.

Create Free Account

Already have an account? Log In

Top Rated Biotechnology Stocks

Top-rated stocks in Biotechnology by analyst ratings.

Stock Analyst Consensus Analyst Target Tradestie Score
VRTX
Vertex Pharmaceuticals I…
BUY
34 analysts
$549 65 BUY
REGN
Regeneron Pharmaceutical…
STRONG BUY
25 analysts
$833 62 BUY
RARE
Ultragenyx
STRONG BUY
20 analysts
$52 63 BUY
LEGN
Legend Biotech Corp
STRONG BUY
22 analysts
$58 52 HOLD
XENE
Xenon Pharmaceuticals Inc
STRONG BUY
19 analysts
$81 58 HOLD

More Analysis for MRVI

MRVI Technical Chart MRVI Price Prediction MRVI Earnings Date MRVI Investment Advisor MRVI Fair Price Analyzer MRVI Competitors
Live Trades
From trading groups
Loading trades...
View All Live Trades See Trader Consensus & Signals